Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
@peckham yep that one's painful atm and unexpectedly so, but still hopeful for a good turnaround - just patience... been saying that to myself for a while now...
Once some articles are out for this big pharma collaboration all eyes will be on here. And as @jhfh reminded us, Lilly are on the hunt quarterly for takeovers - we dreamt about that a few weeks back, it's definitely firmly on the cards now!
@peckham haha thought so. All good here buddy, this one's put a smile on my face today at least - although can't believe it's still at placing price but should definitely shift north over next few days leading to Q&A.
Hope all's good with you too
@latino it's the same RNS as 26 June except they've replaced Globalco with Eli Lilly!!!
A.M.A.Z.I.N.G N.E.W.S and as @manifesto and others have said, clears the path to answer all the Q&As now :-)
@sparster let's hope so, although it's looking a bit flat first thing... As you say though pog is doing well holding around $1800.
Based on SHG timelines I think we're due news first thing next week, so will be interesting to see if the sp builds in anticipation of this
For those that comment on here that “Covid is over”, “It’s gone away”, “Tests aren’t needed” etc etc then NCYT has once again proven that demand is increasing:
“Demand for the Company's COVID-19 test remains strong, with June sales of €25.4 million (£22.5 million) showing the sixth consecutive month of growth. Certain contracts for the supply of the test have also been extended into the second half of the year and in some cases into 2021.”
I’m looking forward to when we’re hopefully looking at those kind of monthly numbers too!
@PP I don’t understand what you mean by teething issues..?
“ - CE marking of software - as Marve(?) identified, not on PI radars this was required, plus software release emphasises DB’s highlighted teething issues appear a greater obstacle than PI’s viewed to securing orders.”
@lp I'm fairly sure they know the score, particularly as we're now at a level where the Directors topped up at.
I can understand people are frustrated at the sp, I'm one of them as I was expecting it to be way north of here even just on potential, but there's no need to get unpleasant with GDR... It's amazing how people can't appreciate what GDR have achieved to date and just have some patience whilst these approvals are earned and the products starts selling to enable the sp to head north. Being aggressive or abusive just isn't on. Those hoping to be in and out in weeks, not months, will be the most annoyed I'm sure, but I think/hope LTHs can see the value here in 1-3 months time
@sparster unfortunately not, but these consecutive +3% days are definitely encouraging